Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00006349

Public ClinicalTrials.gov record NCT00006349. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Exploratory Trial of Donepezil and Vitamin E to Prevent Cognitive Dysfunction in Patients With Small Cell Lung Cancer (SCLC) After Cancer Treatment Which Includes Prophylatic Cranial Irradiation (PCI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Donepezil and vitamin E may be able to decrease side effects caused by radiation therapy given to prevent brain metastases in patients with small cell lung cancer. It is not yet known if donepezil and vitamin E are effective in preventing side effects caused by radiation therapy to the head. PURPOSE: Randomized phase III trial to determine the effectiveness of donepezil and vitamin E in preventing side effects caused by radiation therapy given to prevent brain metastases in patients who have small cell lung cancer.

Study identification

NCT ID
NCT00006349
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
9 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2001 (Type not available)
Primary completion
Jan 2005 (Actual)
Completion
Jan 2007 (Actual)
Last update posted
Jul 13, 2016

2001 – 2007

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
Mayo Clinic Jacksonville Florida 32224 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61602 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016 —
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733 —
CCOP - Wichita Wichita Kansas 67214-3882 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Medcenter One Health System Bismarck North Dakota 58501 —
CCOP - Merit Care Hospital Fargo North Dakota 58122 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212-4772 —
Rapid City Regional Hospital Rapid City South Dakota 57709 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00006349 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →